speb/financial-data huggingface dataset:
Financial ratios for INAC.L — annual report dated 2023-06-30
Total revenue: 0
Gross profit: -84094.93670886075
Operating income: -1909717.7215189873
Net income: -4465694.93670886
Capital expenditures: 0
Operating cash flow: -3470289.8734177216
Net tangible assets: 6012441.772151899
Owner earnings: -4465694.93670886
Return on net tangible assets (%): -74.27423176708045
Buffett classification: The Gruesome
Shares outstanding: 49420712
Book value: 6012441.772151898
Debt to equity: 0
Current ratio: 2.4528852127360525
Quick ratio: 2.4528852127360525
Free cash flow (dilution-adjusted): -3508912.6582278484
Retained earnings: -7719636.708860759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.762764512154025
Rule of 40 score: 0
Financial ratios for INAC.L — annual report dated 2024-06-30
Total revenue: 0
Gross profit: -149594.93670886074
Operating income: -2627918.987341772
Net income: -3760889.873417721
Capital expenditures: 0
Operating cash flow: -2930465.82278481
Net tangible assets: 2320121.518987342
Owner earnings: -3760889.873417721
Return on net tangible assets (%): -162.09883157582317
Buffett classification: The Gruesome
Shares outstanding: 49420712
Book value: 2320121.5189873427
Debt to equity: 0
Current ratio: 1.3216432004138607
Quick ratio: 1.3216432004138607
Free cash flow (dilution-adjusted): -2985541.7721518986
Retained earnings: -11480526.58227848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -113.26643737560661
Rule of 40 score: 0
Financial ratios for KROSS.NS — annual report dated 2023-03-31
Total revenue: 56025091.35200975
Gross profit: 16561144.945188796
Operating income: 6479902.557856273
Net income: 3767478.68453106
Capital expenditures: 2259074.299634592
Operating cash flow: 5084774.665042631
Depreciation & amortization: 526431.1814859927
Net tangible assets: 12434835.566382462
Owner earnings: 2034835.5663824608
Return on net tangible assets (%): 16.363992555588208
Capex to operating income (%): 34.862781954887225
Buffett classification: The Good
Shares outstanding: 64509422
Book value: 12436784.409257002
Debt to equity: 0.8643762364601495
Current ratio: 1.3664525157432732
Quick ratio: 0.8012758185139076
Effective tax rate (%): 25.842723567489806
Interest coverage ratio: 4.665438919582566
COGS to revenue (%): 70.43977163529478
SG&A to revenue (%): 0.7728832131070558
Free cash flow (dilution-adjusted): 2819853.8367844094
Retained earnings: 9838489.64677223
Inventory turnover: 5.209322142903081
Receivables turnover: 8.878452718744573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.16027314721833
FCF margin (%): 5.033198105946961
Rule of 40 score: 5.033198105946961
Financial ratios for KROSS.NS — annual report dated 2024-03-31
Total revenue: 72380141.50377743
Gross profit: 25433385.297997363
Operating income: 8990406.523563977
Net income: 5382060.199064636
Capital expenditures: 3249670.2242475115
Operating cash flow: 989447.1759203741
Depreciation & amortization: 693848.1832353999
Net tangible assets: 17593836.191389855
Owner earnings: 2826238.1580525246
Return on net tangible assets (%): 16.063797157754834
Capex to operating income (%): 36.14597644422509
Buffett classification: The Good
Shares outstanding: 64509422
Book value: 17604628.85238038
Debt to equity: 0.8031061612342905
Current ratio: 1.3667771798134505
Quick ratio: 0.8792857893323681
Effective tax rate (%): 26.772719856420295
Interest coverage ratio: 5.378892237049793
COGS to revenue (%): 64.86137665720089
SG&A to revenue (%): 1.5060191060641706
Free cash flow (dilution-adjusted): -2269936.443218611
Retained earnings: 14361314.306271736
Inventory turnover: 4.687480543116454
Receivables turnover: 5.495165607531091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.49334189349245
FCF margin (%): -3.1361315356093162
Revenue growth (%): 29.19236677189458
Rule of 40 score: 26.056235236285264
Financial ratios for LAES — annual report dated 2022-12-31
Total revenue: 25215217.391304348
Gross profit: 10651086.956521738
Operating income: 2807608.695652174
Net income: 6271739.130434782
Capital expenditures: 325000
Operating cash flow: 484782.60869565216
Depreciation & amortization: 443478.2608695652
Net tangible assets: 229347.8260869565
Owner earnings: 6390217.391304348
Return on net tangible assets (%): 2786.2559241706163
Capex to operating income (%): 11.575687185443282
Buffett classification: The Great
Shares outstanding: 222773999
Book value: 230434.78260869533
Debt to equity: 66.60849056603783
Current ratio: 1.517124576590139
Quick ratio: 0.8105005645464809
Effective tax rate (%): -128.5148514851485
Interest coverage ratio: 4.2694214876033065
COGS to revenue (%): 57.759289593930504
R&D to revenue (%): 9.949133545995345
SG&A to revenue (%): 29.80860419001638
Free cash flow (dilution-adjusted): 159782.60869565216
Retained earnings: -18960869.56521739
Inventory turnover: 1.7841544607190412
Receivables turnover: 9.49570200573066
Capitalized R&D asset: 2508695.652173913
ROCI (R&D-adjusted, %): 30.899367768698312
FCF margin (%): 0.6336753168376584
Rule of 40 score: 0.6336753168376584
Financial ratios for MB — annual report dated 2022-12-31
Total revenue: 58624925.93068036
Gross profit: 21283974.06931964
Operating income: 5573472.913992298
Net income: 4288748.780487805
Capital expenditures: 4144956.7394094993
Operating cash flow: 18102516.944801025
Depreciation & amortization: 8802865.340179717
Net tangible assets: 4261778.177150193
Owner earnings: 8946657.381258022
Return on net tangible assets (%): 209.92780499994393
Capex to operating income (%): 74.36937082807948
Buffett classification: The Good
Shares outstanding: 17155000
Book value: 4261778.17715019
Debt to equity: 7.896971835389549
Current ratio: 0.8014891587654743
Quick ratio: 0.6991058363891407
Effective tax rate (%): 11.59138275289919
Interest coverage ratio: 5.71151337360928
COGS to revenue (%): 63.69466787133111
R&D to revenue (%): 1.3743563707308881
SG&A to revenue (%): 7.96953657917478
Free cash flow (dilution-adjusted): 13929721.309370989
Inventory turnover: 9.312823529325135
Receivables turnover: 108.1407881766167
Capitalized R&D asset: 805715.4043645699
ROCI (R&D-adjusted, %): 30.308200494886346
FCF margin (%): 23.760748671720037
Rule of 40 score: 23.760748671720037
Financial ratios for MB — annual report dated 2023-12-31
Total revenue: 68154430.4737516
Gross profit: 23109832.90653009
Operating income: 514078.74519846356
Net income: -4794636.491677337
Capital expenditures: 5691532.010243278
Operating cash flow: 10732959.154929578
Depreciation & amortization: 10789148.14340589
Net tangible assets: -561772.7272727273
Owner earnings: 302979.64148527477
Capex to operating income (%): 1107.1323339863086
Buffett classification: The Gruesome
Shares outstanding: 17155000
Book value: -561772.7272727266
Debt to equity: -47.54725221626716
Current ratio: 0.7240313371742912
Quick ratio: 0.6421861497029157
Interest coverage ratio: 0.35067856407615516
COGS to revenue (%): 66.09195800494524
R&D to revenue (%): 1.36338990868486
SG&A to revenue (%): 10.446755568305258
Free cash flow (dilution-adjusted): 5033586.0435339315
Retained earnings: -561190.9090909092
Inventory turnover: 13.640502289292872
Receivables turnover: 58.23130849812032
Capitalized R&D asset: 1469039.9483250303
ROCI (R&D-adjusted, %): 7.553352869941883
Rosenberg metric: 2.266133708403428
FCF margin (%): 7.385559542563447
Revenue growth (%): 16.255038947663973
Rule of 40 score: 23.64059849022742
Financial ratios for MB — annual report dated 2024-12-31
Total revenue: 64945290.33505155
Gross profit: 22097783.1185567
Operating income: -747695.1030927835
Net income: 4239747.93814433
Capital expenditures: 1545300.2577319588
Operating cash flow: 7753374.226804124
Depreciation & amortization: 10128986.340206185
Net tangible assets: 3678281.443298969
Owner earnings: 12823434.020618556
Return on net tangible assets (%): 348.62568887924743
Buffett classification: The Gruesome
Shares outstanding: 17155000
Book value: 3678281.4432989657
Debt to equity: 6.596422844823605
Current ratio: 0.829198609801333
Quick ratio: 0.733526968384969
Effective tax rate (%): 7.619743623819645
Interest coverage ratio: -0.5693485150079066
COGS to revenue (%): 65.97477198953973
R&D to revenue (%): 1.176784497081448
SG&A to revenue (%): 10.938487315571695
Free cash flow (dilution-adjusted): 6208073.969072165
Retained earnings: 3674941.1082474226
Inventory turnover: 16.338006033674024
Receivables turnover: 24.340097811390216
Capitalized R&D asset: 1652723.3120462457
ROCI (R&D-adjusted, %): -5.8438321935856266
Rosenberg metric: -1.0891500356645105
FCF margin (%): 9.558928656789162
Revenue growth (%): -4.708630262761851
Rule of 40 score: 4.850298394027311
Financial ratios for MB — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3678281.443298969
Buffett classification: The Gruesome
Shares outstanding: 17155000
Book value: 3678281.4432989657
Debt to equity: 6.596422844823605
Current ratio: 0.829198609801333
Quick ratio: 0.733526968384969
Retained earnings: 3674941.1082474226
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MBX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -25161000
Net income: -26135000
Capital expenditures: 441000
Operating cash flow: -23122000
Depreciation & amortization: 56000
Net tangible assets: -42605000
Owner earnings: -26520000
Buffett classification: The Gruesome
Shares outstanding: 47597536
Book value: -42605000
Debt to equity: -0.010820326252787232
Current ratio: 12.885747595453221
Quick ratio: 12.885747595453221
Interest coverage ratio: -67.27540106951872
Free cash flow (dilution-adjusted): -23869000
Retained earnings: -43020000
Receivables turnover: 0
Capitalized R&D asset: 21397000
ROCI (R&D-adjusted, %): -17.279036699914897
Rule of 40 score: 0
Financial ratios for MBX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -35311000
Net income: -32563000
Capital expenditures: 129000
Operating cash flow: -31978000
Depreciation & amortization: 157000
Net tangible assets: -72468000
Owner earnings: -32535000
Buffett classification: The Gruesome
Shares outstanding: 47597536
Book value: -72468000
Debt to equity: -0.004470938897168405
Current ratio: 21.259551706571575
Quick ratio: 21.259551706571575
Free cash flow (dilution-adjusted): -34150000
Retained earnings: -75583000
Receivables turnover: 0
Capitalized R&D asset: 42869990
ROCI (R&D-adjusted, %): -19.02201729059192
Rule of 40 score: 0
Financial ratios for NUVAMA.NS — annual report dated 2023-03-31
Total revenue: 161139220.46285018
Gross profit: 50348233.861144945
Operating income: -11741778.319123022
Net income: 37160901.33982948
Capital expenditures: 9395980.511571255
Operating cash flow: -227151278.92813644
Depreciation & amortization: 10789524.96954933
Net tangible assets: 266618514.0073082
Owner earnings: 38554445.79780756
Return on net tangible assets (%): 14.460528347536568
Buffett classification: The Gruesome
Shares outstanding: 182528816
Book value: 275127771.01096225
Debt to equity: 2.3897544668649138
Current ratio: 1.489776047781761
Quick ratio: 1.489776047781761
Effective tax rate (%): 24.877245169837526
Interest coverage ratio: -0.25401242131280155
COGS to revenue (%): 68.75482348957219
SG&A to revenue (%): 7.767169355222749
Free cash flow (dilution-adjusted): -239598781.97320342
Retained earnings: -86354202.19244824
Receivables turnover: 1.5110258551076887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.835462933644778
FCF margin (%): -148.69054305028223
Rule of 40 score: -148.69054305028223
Financial ratios for PBK — annual report dated 2022-06-30
Total revenue: 7905131.007751938
Gross profit: 1524141.8604651163
Operating income: -279493.0232558139
Net income: -146041.08527131783
Capital expenditures: 8503.875968992248
Operating cash flow: 132722.48062015502
Depreciation & amortization: 19986.046511627905
Net tangible assets: 3477001.5503875967
Owner earnings: -134558.91472868217
Return on net tangible assets (%): -3.8699699375653798
Buffett classification: The Gruesome
Shares outstanding: 53956787
Book value: 3442337.2093023253
Debt to equity: 0.47563727096359404
Current ratio: 2.6688508215759845
Quick ratio: 2.610643662677749
Interest coverage ratio: -2.3891458485189845
COGS to revenue (%): 80.7195875821601
SG&A to revenue (%): 22.097344487963316
Free cash flow (dilution-adjusted): 124218.6046511628
Retained earnings: 3419042.6356589147
Inventory turnover: 42.014475296039194
Receivables turnover: 4.6348052427341555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.185778196858678
FCF margin (%): 1.5713668063103752
Rule of 40 score: 1.5713668063103752
Financial ratios for PBK — annual report dated 2023-06-30
Total revenue: 13832713.533834586
Gross profit: 3411428.5714285714
Operating income: -2012133.082706767
Net income: 1685703.7593984962
Capital expenditures: 0
Operating cash flow: 1797680.4511278195
Depreciation & amortization: 36999.24812030075
Net tangible assets: 11493449.62406015
Owner earnings: 1722703.007518797
Return on net tangible assets (%): 14.988563606808924
Buffett classification: The Gruesome
Shares outstanding: 53956787
Book value: 12504658.64661654
Debt to equity: 0.06515953512904303
Current ratio: 3.112123786469441
Quick ratio: 3.048779792305794
Effective tax rate (%): 29.78785904871663
Interest coverage ratio: -21.366022099447516
COGS to revenue (%): 75.33796559088516
SG&A to revenue (%): 37.04767857431134
Free cash flow (dilution-adjusted): -1261954.1353383458
Retained earnings: 5001918.045112781
Inventory turnover: 30.88847858691704
Receivables turnover: 1.636341683452558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.96247189298735
FCF margin (%): -9.122968767130375
Revenue growth (%): 74.98398850404801
Rule of 40 score: 65.86101973691764
Financial ratios for PROTEAN.NS — annual report dated 2023-03-31
Total revenue: 89017052.37515226
Gross profit: 36071863.580998786
Operating income: 12157125.456760049
Net income: 13037758.830694277
Capital expenditures: 1493300.8526187576
Operating cash flow: 16685749.086479904
Depreciation & amortization: 2226552.9841656517
Net tangible assets: 102566382.46041414
Owner earnings: 13771010.96224117
Return on net tangible assets (%): 13.426437232059094
Capex to operating income (%): 12.283338342851417
Buffett classification: The Great
Shares outstanding: 40621194
Book value: 104375152.25334957
Debt to equity: 0.009242403024786445
Current ratio: 1.7891039992975988
Quick ratio: 1.7891039992975988
Effective tax rate (%): 23.771542515311207
Interest coverage ratio: 107.32258064516128
COGS to revenue (%): 59.4775802854289
SG&A to revenue (%): 4.015981828879493
Free cash flow (dilution-adjusted): 13495736.906211937
Retained earnings: 45202192.448233865
Receivables turnover: 3.4991381786842863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.389804977690545
FCF margin (%): 15.16084451924524
Rule of 40 score: 15.16084451924524
Financial ratios for PROTEAN.NS — annual report dated 2024-03-31
Total revenue: 105038973.49802135
Gross profit: 41540952.15253627
Operating income: 7709557.500899388
Net income: 11666866.530759083
Capital expenditures: 991725.6265739297
Operating cash flow: 6900107.926609905
Depreciation & amortization: 3295359.1557740737
Net tangible assets: 106991245.95275213
Owner earnings: 13970500.059959227
Return on net tangible assets (%): 13.057610401255323
Capex to operating income (%): 12.86358687198631
Buffett classification: The Great
Shares outstanding: 40621194
Book value: 111043290.56241755
Debt to equity: 0.022451646346072853
Current ratio: 1.951872374653678
Quick ratio: 1.951872374653678
Effective tax rate (%): 23.90896292820272
Interest coverage ratio: 38.49700598802395
COGS to revenue (%): 60.451867750479494
SG&A to revenue (%): 5.169421865010502
Free cash flow (dilution-adjusted): 1528960.3069912458
Retained earnings: 51069672.62261662
Receivables turnover: 4.627397115537007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.68670563517983
FCF margin (%): 1.4556123846926659
Revenue growth (%): 17.998710017207177
Rule of 40 score: 19.454322401899844
Financial ratios for PROTEAN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 107140468.22742476
Buffett classification: The Gruesome
Shares outstanding: 40621194
Book value: 113317009.07787865
Debt to equity: 0.020554659583214747
Current ratio: 1.7188599062133645
Quick ratio: 1.7188599062133645
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PROTEAN.NS — quarterly report dated 2024-12-31
Total revenue: 23582002.564401444
Gross profit: 4627578.971908147
Operating income: 1162140.10956988
Net income: 2672805.6883086604
Capital expenditures: 0
Depreciation & amortization: 677235.1089870614
Owner earnings: 3350040.7972957217
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40621194
Effective tax rate (%): 19.600280504908838
Interest coverage ratio: 38.34615384615385
COGS to revenue (%): 80.37664969601107
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RAY — annual report dated 2022-03-31
Total revenue: 5760653.512132823
Gross profit: 1545903.7037037036
Operating income: 1427418.5185185184
Net income: 1205669.220945083
Capital expenditures: 1494.2528735632184
Operating cash flow: 1050950.7024265644
Depreciation & amortization: 4792.848020434228
Net tangible assets: 1895994.5083014048
Owner earnings: 1208967.816091954
Return on net tangible assets (%): 63.76431001242992
Capex to operating income (%): 0.10468218354866697
Buffett classification: The Great
Shares outstanding: 5874743
Book value: 1895994.5083014048
Debt to equity: 0.012718955744371225
Current ratio: 3.47128036815902
Quick ratio: 3.47128036815902
Effective tax rate (%): 15.56287274008088
Interest coverage ratio: 6668.667661097852
COGS to revenue (%): 73.16443871432655
SG&A to revenue (%): 2.9762414540868325
Free cash flow (dilution-adjusted): 1049456.4495530012
Retained earnings: 1883223.116219668
Receivables turnover: 5.4576428132817485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 74.84250458144443
FCF margin (%): 18.217663106150795
Rule of 40 score: 18.217663106150795
Financial ratios for RAY — annual report dated 2023-03-31
Total revenue: 5798501.783439491
Gross profit: 1461395.1592356688
Operating income: 916468.1528662421
Net income: 801639.49044586
Capital expenditures: 0
Operating cash flow: 1396411.719745223
Depreciation & amortization: 14840.382165605097
Net tangible assets: 2692803.439490446
Owner earnings: 816479.872611465
Return on net tangible assets (%): 30.3208121557497
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 5874743
Book value: 2692803.439490446
Debt to equity: 0.00416169410640023
Current ratio: 2.497172451025915
Quick ratio: 2.497172451025915
Effective tax rate (%): 15.802350732399544
Interest coverage ratio: 1006.051601174661
COGS to revenue (%): 74.79702147528158
SG&A to revenue (%): 9.141788196155831
Free cash flow (dilution-adjusted): 1396411.719745223
Retained earnings: 2680064.5859872615
Receivables turnover: 5.488514008129151
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.0339788424982
FCF margin (%): 24.08228490561772
Revenue growth (%): 0.6570135007591434
Rule of 40 score: 24.73929840637686
Financial ratios for RAY — annual report dated 2024-03-31
Total revenue: 8553295.146871008
Gross profit: 1903558.748403576
Operating income: 1450765.772669221
Net income: 1269066.9220945083
Capital expenditures: 0
Operating cash flow: 2011274.4572158365
Depreciation & amortization: 11538.31417624521
Net tangible assets: 3968748.5312899104
Owner earnings: 1280605.2362707534
Return on net tangible assets (%): 32.26723049279555
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 5874743
Book value: 3968748.5312899104
Debt to equity: 0
Current ratio: 1.9544569468578945
Quick ratio: 1.88582370113922
Effective tax rate (%): 22.087545086583646
Interest coverage ratio: 5601.329388560159
COGS to revenue (%): 77.74473210947315
SG&A to revenue (%): 5.15888501426881
Free cash flow (dilution-adjusted): 2011274.4572158365
Retained earnings: 3955977.139208174
Inventory turnover: 28.05832236703839
Receivables turnover: 4.435929155803528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.55474165801323
FCF margin (%): 23.51461539301151
Revenue growth (%): 47.50870942730761
Rule of 40 score: 71.02332482031912
Financial ratios for RHR.L — annual report dated 2023-09-30
Total revenue: 283864.9268292683
Gross profit: 97953.39024390244
Operating income: -518753.15853658546
Net income: -636697.0365853659
Capital expenditures: 0
Operating cash flow: -93955.29268292683
Net tangible assets: -2998.5731707317073
Owner earnings: -636697.0365853659
Buffett classification: The Gruesome
Shares outstanding: 675827074
Book value: 3559306.3536585374
Debt to equity: 0.05167087896658241
Current ratio: 0.9650756693830034
Quick ratio: 0.3853317811408613
Interest coverage ratio: -259.5
COGS to revenue (%): 65.49295774647888
SG&A to revenue (%): 137.6760563380282
Free cash flow (dilution-adjusted): -94954.81707317072
Retained earnings: -2989577.451219512
Inventory turnover: 0.3734939759036144
Receivables turnover: 2.8686868686868685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.574557708508845
FCF margin (%): -33.45070422535211
Rule of 40 score: -33.45070422535211
Financial ratios for RHR.L — annual report dated 2024-09-30
Total revenue: 0
Gross profit: 0
Operating income: -331787.88
Net income: -4244493.600000001
Capital expenditures: 0
Operating cash flow: -123548.64
Net tangible assets: -331787.88
Owner earnings: -4244493.600000001
Buffett classification: The Gruesome
Shares outstanding: 675827074
Book value: -397547.64
Debt to equity: -0.5488721804511278
Current ratio: 0.6163461538461539
Quick ratio: 0.5259615384615385
Interest coverage ratio: -166.5
Free cash flow (dilution-adjusted): -126537.72
Retained earnings: -7220620.920000001
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for RHR.L — annual report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -450548.7567567568
Net income: -1266162.689189189
Capital expenditures: 0
Operating cash flow: -455577.2027027027
Net tangible assets: -1042899.6891891892
Owner earnings: -1266162.689189189
Buffett classification: The Gruesome
Shares outstanding: 675827074
Book value: -1260128.554054054
Debt to equity: -0.1644054269752594
Current ratio: 0.09661139149242971
Quick ratio: 0.09661139149242971
Interest coverage ratio: -40.72727272727273
Free cash flow (dilution-adjusted): -455577.2027027027
Retained earnings: -8552380.864864865
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RHR.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -1042899.6891891892
Buffett classification: The Gruesome
Shares outstanding: 675827074
Book value: -1260128.554054054
Debt to equity: -0.1644054269752594
Current ratio: 0.09661139149242971
Quick ratio: 0.09661139149242971
Retained earnings: -8552380.864864865
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURAKSHA.NS — annual report dated 2023-03-31
Total revenue: 23158830.694275275
Gross profit: 19820950.06090134
Operating income: 1921802.6796589526
Net income: 793666.2606577345
Capital expenditures: 1523264.31181486
Operating cash flow: 5371010.96224117
Depreciation & amortization: 3857612.667478685
Net tangible assets: 18815712.545676008
Owner earnings: 3128014.6163215595
Return on net tangible assets (%): 16.624481314370424
Capex to operating income (%): 79.26226391177589
Buffett classification: The Gruesome
Shares outstanding: 52080758
Book value: 18935566.382460415
Debt to equity: 0.6231402087983481
Current ratio: 1.7748885005607573
Quick ratio: 1.6141728176103909
Effective tax rate (%): 10.121517486662714
Interest coverage ratio: 1.7415011037527595
COGS to revenue (%): 14.41299294181998
SG&A to revenue (%): 18.77991311390914
Free cash flow (dilution-adjusted): 3767235.079171742
Retained earnings: 12061632.155907432
Inventory turnover: 4.447257383966244
Receivables turnover: 40.62692307692307
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.496907607039621
FCF margin (%): 16.266948573111595
Rule of 40 score: 16.266948573111595
Financial ratios for SURAKSHA.NS — annual report dated 2024-03-31
Total revenue: 26227185.51385058
Gross profit: 22959263.700683534
Operating income: 4912723.348123276
Net income: 2833121.477395371
Capital expenditures: 5146972.05899988
Operating cash flow: 7252824.079625854
Depreciation & amortization: 3909101.8107686774
Net tangible assets: 21385321.981052883
Owner earnings: 1595251.2291641682
Return on net tangible assets (%): 7.459561425250179
Capex to operating income (%): 104.76820480774865
Buffett classification: The Gruesome
Shares outstanding: 52080758
Book value: 21482899.628252786
Debt to equity: 0.5050425379537015
Current ratio: 1.838245517885325
Quick ratio: 1.6687979864102995
Effective tax rate (%): 26.47261743899531
Interest coverage ratio: 4.661561394126281
COGS to revenue (%): 12.460055279058656
SG&A to revenue (%): 17.342124334445163
Free cash flow (dilution-adjusted): 1799844.1060079145
Retained earnings: 14691066.075068953
Inventory turnover: 4.080559423805459
Receivables turnover: 24.64348894072046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.708721908243595
FCF margin (%): 6.862513345388955
Revenue growth (%): 13.249178510268159
Rule of 40 score: 20.111691855657114
Financial ratios for SURAKSHA.NS — quarterly report dated 2024-09-30
Capital expenditures: 1471500.2388915434
Operating cash flow: 2261383.182035356
Depreciation & amortization: 1054670.3296703296
Net tangible assets: 23374868.60965122
Buffett classification: The Gruesome
Shares outstanding: 52080758
Book value: 23506903.96559962
Debt to equity: 0.43430277876298656
Current ratio: 1.9113101122802063
Quick ratio: 1.7600584351387616
Free cash flow (dilution-adjusted): 771978.021978022
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMPV.NS — annual report dated 2023-03-31
Total revenue: 41763043848.96468
Gross profit: 13982377588.306944
Operating income: -869361753.9585872
Net income: 327633373.9342266
Capital expenditures: 999707673.5688186
Operating cash flow: 4310354445.797808
Depreciation & amortization: 3028058465.2862363
Net tangible assets: -1374924482.3386116
Owner earnings: 2355984165.651644
Return on net tangible assets (%): -171.35371403412253
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Book value: 6406761266.747871
Debt to equity: 2.597238073130338
Current ratio: 0.9774306261076273
Quick ratio: 0.7145389967988873
Effective tax rate (%): 20.74468241831741
Interest coverage ratio: -0.6980073307072137
COGS to revenue (%): 66.51973539363182
R&D to revenue (%): 3.10958009457627
SG&A to revenue (%): 3.9615125751954956
Free cash flow (dilution-adjusted): 2102594397.0767357
Retained earnings: 3075641900.121803
Inventory turnover: 5.596297078742223
Receivables turnover: 21.786455940632752
Capitalized R&D asset: 1298655298.4165652
ROCI (R&D-adjusted, %): -0.015380389047688977
FCF margin (%): 5.034581302743956
Rule of 40 score: 5.034581302743956
Financial ratios for TMPV.NS — annual report dated 2024-03-31
Total revenue: 51710277011.63209
Gross profit: 18750329775.752487
Operating income: 1004556901.3071111
Net income: 3814246312.507495
Capital expenditures: 1528240796.2585442
Operating cash flow: 8144261901.906703
Depreciation & amortization: 3270176280.129512
Net tangible assets: 2405084542.5110927
Owner earnings: 5556181796.378463
Return on net tangible assets (%): 231.0181491822896
Capex to operating income (%): 152.13083442759938
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Book value: 11163688691.689651
Debt to equity: 1.1795819279437987
Current ratio: 0.9099417479925213
Quick ratio: 0.651709193874353
Effective tax rate (%): -14.154560484012805
Interest coverage ratio: 1.103107716618383
COGS to revenue (%): 63.73964546441194
R&D to revenue (%): 2.541441332801499
SG&A to revenue (%): 4.199558453846368
Free cash flow (dilution-adjusted): 4371987048.806811
Retained earnings: 6620703921.333493
Inventory turnover: 5.751506654390223
Receivables turnover: 25.437234544596507
Capitalized R&D asset: 2184285403.2188683
ROCI (R&D-adjusted, %): 5.9234257559311665
Rosenberg metric: 3.6714532280113517
FCF margin (%): 8.454773985881655
Revenue growth (%): 23.818266692057694
Rule of 40 score: 32.27304067793935
Financial ratios for TMPV.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 3024247491.638796
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Book value: 13049211657.907314
Debt to equity: 0.9752947422378438
Current ratio: 0.9390173768902018
Quick ratio: 0.6307100731836582
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMPV.NS — quarterly report dated 2025-03-31
Total revenue: 11440612578.91045
Gross profit: 4457446808.510638
Operating income: 249941547.81388822
Net income: 1000233808.744447
Capital expenditures: 0
Depreciation & amortization: 551437923.7783493
Net tangible assets: 3896656534.954407
Owner earnings: 1551671732.5227962
Return on net tangible assets (%): 39.82059282371295
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 3682582902
Book value: 14350479307.926117
Debt to equity: 0.602864265115597
Current ratio: 0.9618499676033692
Quick ratio: 0.6782654603921192
Effective tax rate (%): 26.769822006472495
Interest coverage ratio: 2.582125603864734
COGS to revenue (%): 61.038390402910196
R&D to revenue (%): 2.404381635551741
Retained earnings: 9428805237.315874
Inventory turnover: 1.2637034843131862
Receivables turnover: 7.387001811594203
Capitalized R&D asset: 275075987.8419453
ROCI (R&D-adjusted, %): 1.7295736880825838
Rule of 40 score: 0
Financial ratios for TMPV.NS — annual report dated 2025-03-31
Total revenue: 42493102642.03881
Gross profit: 16404722936.637829
Operating income: -92705167.17325227
Net income: 3290741173.719897
Capital expenditures: 1661795651.1573532
Operating cash flow: 7376899696.048632
Depreciation & amortization: 2718728080.4302077
Net tangible assets: 3896656534.954407
Owner earnings: 4347673602.992751
Return on net tangible assets (%): 111.57446297851912
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Book value: 14350479307.926117
Debt to equity: 0.602864265115597
Current ratio: 0.9618499676033692
Quick ratio: 0.6782654603921192
Effective tax rate (%): 31.840865959091868
Interest coverage ratio: -0.20328120994616766
COGS to revenue (%): 61.39438657885036
R&D to revenue (%): 2.838623770929279
SG&A to revenue (%): 5.0205509978376055
Free cash flow (dilution-adjusted): 2924012158.0547113
Retained earnings: 9428805237.315874
Inventory turnover: 4.721064545473778
Receivables turnover: 27.437047101449277
Capitalized R&D asset: 2515280417.7772036
ROCI (R&D-adjusted, %): -0.5843980622790489
Rosenberg metric: -1.7848357907999943
FCF margin (%): 6.881145353603715
Revenue growth (%): -17.824647057140883
Rule of 40 score: -10.943501703537168
Financial ratios for TMPV.NS — quarterly report dated 2025-06-30
Total revenue: 12145097121.460333
Gross profit: 4318043529.136438
Operating income: -389304937.982682
Net income: 468406271.940089
Capital expenditures: 0
Depreciation & amortization: 622513456.5878774
Owner earnings: 1090919728.5279665
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Effective tax rate (%): 28.016543787088654
Interest coverage ratio: -3.546908315565032
COGS to revenue (%): 64.44620009249267
R&D to revenue (%): 2.424078927084939
Capitalized R&D asset: 478707651.8494228
ROCI (R&D-adjusted, %): -59.4780076802862
Rosenberg metric: -0.506780982476373
Revenue growth (%): 6.157751935840613
Rule of 40 score: 6.157751935840613
Financial ratios for TMPV.NS — quarterly report dated 2025-09-30
Total revenue: 8085005636.9785795
Gross profit: 2679594137.5422773
Operating income: -1523111612.1758738
Net income: 8596166854.565952
Capital expenditures: 0
Depreciation & amortization: 549154453.2130778
Net tangible assets: 1975873731.6798196
Owner earnings: 9145321307.77903
Return on net tangible assets (%): 462.84948077142525
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Book value: 13229650507.328075
Debt to equity: 0.5731548313974791
Current ratio: 0.8976540869146504
Quick ratio: 0.5949726134585291
Interest coverage ratio: -19.69387755102041
COGS to revenue (%): 66.85723847505368
R&D to revenue (%): 4.934880218646289
Inventory turnover: 1.1917971662938107
Receivables turnover: 9.67800269905533
Capitalized R&D asset: 687012935.6403993
ROCI (R&D-adjusted, %): -5.902361409410947
Rosenberg metric: -5.565257750621502
Revenue growth (%): -33.42988074840167
Rule of 40 score: -33.42988074840167
Financial ratios for TMPV.NS — quarterly report dated 2025-12-31
Total revenue: 7753703909.992203
Gross profit: 2872006238.1641974
Operating income: -1322156622.4796703
Net income: -387991533.92001784
Capital expenditures: 0
Depreciation & amortization: 553525676.7294197
Owner earnings: 165534142.80940187
Buffett classification: The Gruesome
Shares outstanding: 3682582902
Interest coverage ratio: -17.403225806451612
COGS to revenue (%): 62.959557503052935
R&D to revenue (%): 4.654838014510452
Capitalized R&D asset: 725396761.7166704
ROCI (R&D-adjusted, %): -180.95923246660223
Rosenberg metric: 0.48225355538751946
Revenue growth (%): -4.097730315376582
Rule of 40 score: -4.097730315376582
Financial ratios for VGNT — annual report dated 2022-12-31
Total revenue: 8711956521.73913
Gross profit: 944565217.3913043
Operating income: 546739130.4347826
Net income: 493478260.8695652
Capital expenditures: 1086956.5217391304
Operating cash flow: 658695652.173913
Depreciation & amortization: 207608695.6521739
Owner earnings: 700000000
Capex to operating income (%): 0.19880715705765406
Buffett classification: The Great
Shares outstanding: 70893660
Effective tax rate (%): 10.927835051546392
COGS to revenue (%): 89.15782907049284
SG&A to revenue (%): 4.379288833437305
Free cash flow (dilution-adjusted): 385869565.2173913
Capitalized R&D asset: 0
FCF margin (%): 4.429195258889583
Rule of 40 score: 4.429195258889583
Financial ratios for VGNT — annual report dated 2023-12-31
Total revenue: 10514285714.285715
Gross profit: 1232142857.142857
Operating income: 755952380.952381
Net income: 538095238.0952381
Capital expenditures: 1190476.1904761905
Operating cash flow: 214285714.2857143
Depreciation & amortization: 244047619.04761904
Net tangible assets: 2119047619.047619
Owner earnings: 780952380.9523809
Return on net tangible assets (%): 36.853932584269664
Capex to operating income (%): 0.15748031496062992
Buffett classification: The Great
Shares outstanding: 70893660
Book value: 2365476190.47619
Debt to equity: 0.13739305485656772
Current ratio: 1.2826923076923076
Quick ratio: 0.9139423076923077
Effective tax rate (%): 24.699828473413376
COGS to revenue (%): 88.28124999999999
SG&A to revenue (%): 4.3931159420289845
Free cash flow (dilution-adjusted): -105952380.95238096
Inventory turnover: 10.165580182529334
Receivables turnover: 5.301320528211284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.311827956989255
FCF margin (%): -1.0076992753623188
Revenue growth (%): 20.687995722306404
Rule of 40 score: 19.680296446944084
Financial ratios for VGNT — quarterly report dated 2024-12-31
Total revenue: 2364444444.444444
Gross profit: 313333333.3333333
Operating income: 197777777.77777776
Net income: 142222222.2222222
Capital expenditures: 44444444.44444444
Operating cash flow: 463333333.3333333
Depreciation & amortization: 57777777.777777776
Net tangible assets: 1685555555.5555556
Owner earnings: 155555555.55555555
Return on net tangible assets (%): 9.22874093605801
Capex to operating income (%): 22.47191011235955
Buffett classification: The Great
Shares outstanding: 70893660
Book value: 1913333333.333333
Debt to equity: 0.24332171893147506
Current ratio: 1.1634890371782651
Quick ratio: 0.8255481410867493
Effective tax rate (%): 5.511811023622048
COGS to revenue (%): 86.74812030075189
SG&A to revenue (%): 4.840225563909775
Free cash flow (dilution-adjusted): 411111111.1111111
Inventory turnover: 2.603667136812412
Receivables turnover: 1.4064771976206212
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.704156479217605
FCF margin (%): 17.387218045112785
Rule of 40 score: 17.387218045112785
Financial ratios for VGNT — annual report dated 2024-12-31
Total revenue: 9232222222.222221
Gross profit: 1078888888.8888888
Operating income: 620000000
Net income: 482222222.2222222
Capital expenditures: 0
Operating cash flow: 785555555.5555556
Depreciation & amortization: 224444444.44444445
Net tangible assets: 1685555555.5555556
Owner earnings: 706666666.6666666
Return on net tangible assets (%): 41.92485168094924
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 70893660
Book value: 1913333333.333333
Debt to equity: 0.24332171893147506
Current ratio: 1.1634890371782651
Quick ratio: 0.8255481410867493
Effective tax rate (%): 8.647450110864746
COGS to revenue (%): 88.31387651943676
SG&A to revenue (%): 4.946443615356842
Free cash flow (dilution-adjusted): 525555555.5555555
Inventory turnover: 10.349788434414668
Receivables turnover: 5.491738268341043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.286063569682156
FCF margin (%): 5.692622457576123
Revenue growth (%): -12.193538647343011
Rule of 40 score: -6.500916189766889
Financial ratios for VGNT — quarterly report dated 2025-03-31
Total revenue: 2300000000
Gross profit: 282954545.45454544
Operating income: 163636363.63636363
Net income: 109090909.0909091
Capital expenditures: 42045454.54545455
Operating cash flow: 45454545.45454545
Depreciation & amortization: 59090909.09090909
Owner earnings: 126136363.63636364
Capex to operating income (%): 25.694444444444446
Buffett classification: The Good
Shares outstanding: 70893660
Effective tax rate (%): 24.166666666666664
Interest coverage ratio: 71.99999999999999
COGS to revenue (%): 87.69762845849802
SG&A to revenue (%): 5.187747035573122
Free cash flow (dilution-adjusted): -5681818.181818183
Capitalized R&D asset: 0
FCF margin (%): -0.2470355731225297
Revenue growth (%): -2.7255639097744253
Rule of 40 score: -2.972599482896955
Financial ratios for VGNT — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 2205000000
Buffett classification: The Gruesome
Shares outstanding: 70893660
Book value: 2441250000
Debt to equity: 0.07578084997439836
Current ratio: 1.3552694325226513
Quick ratio: 0.9761564139246542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VGNT — annual report dated 2025-12-31
Total revenue: 11162025316.455696
Gross profit: 1369620253.164557
Operating income: 837974683.5443038
Net income: 645569620.2531645
Capital expenditures: 1265822.7848101265
Operating cash flow: 811392405.0632911
Depreciation & amortization: 287341772.15189874
Net tangible assets: 2079746835.443038
Owner earnings: 931645569.6202531
Return on net tangible assets (%): 44.79610468654899
Capex to operating income (%): 0.1510574018126888
Buffett classification: The Great
Shares outstanding: 70893660
Book value: 2330379746.835443
Debt to equity: 0.37914177077675176
Current ratio: 1.4967860422405879
Quick ratio: 1.1423324150596879
Effective tax rate (%): -1.4285714285714286
COGS to revenue (%): 87.72964391018373
SG&A to revenue (%): 4.751644363801315
Free cash flow (dilution-adjusted): 567088607.5949366
Inventory turnover: 10.020725388601036
Receivables turnover: 5.2519356759976175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.483504788932244
FCF margin (%): 5.0805171240644125
Revenue growth (%): 20.90290991467237
Rule of 40 score: 25.983427038736785
Financial ratios for VGNT — quarterly report dated 2025-12-31
Total revenue: 2913924050.632911
Gross profit: 346835443.03797466
Operating income: 212658227.84810126
Net income: 244303797.46835443
Capital expenditures: 46835443.03797468
Operating cash flow: 288607594.93670887
Depreciation & amortization: 77215189.87341772
Net tangible assets: 2079746835.443038
Owner earnings: 274683544.3037975
Return on net tangible assets (%): 13.20754716981132
Capex to operating income (%): 22.023809523809522
Buffett classification: The Great
Shares outstanding: 70893660
Book value: 2330379746.835443
Debt to equity: 0.37914177077675176
Current ratio: 1.4967860422405879
Quick ratio: 1.1423324150596879
Effective tax rate (%): -135.80246913580248
COGS to revenue (%): 88.09730668983492
SG&A to revenue (%): 4.604691572545613
Free cash flow (dilution-adjusted): 230379746.83544302
Inventory turnover: 2.6269430051813467
Receivables turnover: 1.3710541989279332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.95956012770486
FCF margin (%): 7.90616854908775
Rule of 40 score: 7.90616854908775
Financial ratios for WAY — annual report dated 2022-12-31
Total revenue: 704874000
Gross profit: 489983000
Operating income: 89450000
Net income: -51455000
Capital expenditures: 17433000
Operating cash flow: 102634000
Depreciation & amortization: 183167000
Net tangible assets: -2229868000
Owner earnings: 114279000
Capex to operating income (%): 19.48910005589715
Buffett classification: The Great
Shares outstanding: 191812891
Book value: 2106232000
Debt to equity: 1.0736642497122824
Current ratio: 2.131833835557469
Quick ratio: 2.131833835557469
Interest coverage ratio: 0.5758892644455175
COGS to revenue (%): 30.48644154841858
R&D to revenue (%): 4.6543070108984015
SG&A to revenue (%): 26.18326112184589
Free cash flow (dilution-adjusted): 77198000
Retained earnings: -150441000
Receivables turnover: 6.325540907989554
Capitalized R&D asset: 32807000
ROCI (R&D-adjusted, %): 2.4069545132415144
FCF margin (%): 10.952028305768122
Rule of 40 score: 10.952028305768122
Financial ratios for WAY — annual report dated 2023-12-31
Total revenue: 791010000
Gross profit: 541243000
Operating income: 142083000
Net income: -51334000
Capital expenditures: 21517000
Operating cash flow: 51460000
Depreciation & amortization: 176467000
Net tangible assets: -2167018000
Owner earnings: 103616000
Capex to operating income (%): 15.14396514713231
Buffett classification: The Great
Shares outstanding: 191812891
Book value: 2049932000
Debt to equity: 1.0972812756715833
Current ratio: 1.7981358663524687
Quick ratio: 1.7981358663524687
Interest coverage ratio: 0.6900013112079139
COGS to revenue (%): 31.575707007496746
R&D to revenue (%): 4.4666944792101235
SG&A to revenue (%): 23.68629979393434
Free cash flow (dilution-adjusted): 21095000
Retained earnings: -201775000
Receivables turnover: 5.951918735891648
Capitalized R&D asset: 57312690
ROCI (R&D-adjusted, %): 3.425037174954807
Rosenberg metric: 1.56247142378151
FCF margin (%): 2.666843655579575
Revenue growth (%): 12.220056350496684
Rule of 40 score: 14.886900006076258
Financial ratios for YDES — annual report dated 2023-12-31
Total revenue: 11404.918566775244
Gross profit: 4998.208469055375
Operating income: -231.7915309446254
Net income: 441.6938110749186
Capital expenditures: 9.446254071661238
Operating cash flow: -1812.9315960912052
Depreciation & amortization: 79.86970684039088
Net tangible assets: 748.9902280130293
Owner earnings: 512.1172638436483
Return on net tangible assets (%): 68.37435852831175
Buffett classification: The Gruesome
Shares outstanding: 70831346
Book value: 748.99022801303
Debt to equity: 2.0690614943028596
Current ratio: 0.9111589508346243
Quick ratio: 0.6784298734482829
Effective tax rate (%): 23.172804532577903
Interest coverage ratio: -3.3190298507462686
COGS to revenue (%): 56.17497450954071
R&D to revenue (%): 0
SG&A to revenue (%): 45.857407655991615
Free cash flow (dilution-adjusted): -1822.3778501628665
Retained earnings: -16791.00977198697
Inventory turnover: 2.833928880179817
Receivables turnover: 3.55701282077331
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.94720361833519
FCF margin (%): -15.978876477661219
Rule of 40 score: -15.978876477661219
Financial ratios for YDES — annual report dated 2024-12-31
Total revenue: 15578.75457875458
Gross profit: 4742.246642246642
Operating income: -44640.506715506715
Net income: -43087.881562881565
Capital expenditures: 2286.7521367521367
Operating cash flow: -37322.37484737485
Depreciation & amortization: 3197.0390720390724
Net tangible assets: 119359.31013431014
Owner earnings: -42177.59462759463
Return on net tangible assets (%): -35.33666086050088
Buffett classification: The Gruesome
Shares outstanding: 70831346
Book value: 201167.46031746033
Debt to equity: 0.0033784778292039476
Current ratio: 13.182855622291493
Quick ratio: 13.040929825895233
Interest coverage ratio: -1894.3303108808288
COGS to revenue (%): 69.55952660866839
R&D to revenue (%): 96.27576612587193
SG&A to revenue (%): 218.7136531076103
Free cash flow (dilution-adjusted): -126180.55555555556
Retained earnings: -58823.046398046405
Inventory turnover: 9.508611222713272
Receivables turnover: 1.9420386916087005
Capitalized R&D asset: 14998.565323565324
ROCI (R&D-adjusted, %): -16.000723203326395
FCF margin (%): -809.9527784309114
Revenue growth (%): 36.59680678596457
Rule of 40 score: -773.3559716449469
Financial ratios for YDES — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 75167.51460983156
Buffett classification: The Gruesome
Shares outstanding: 70831346
Book value: 174910.65658301822
Debt to equity: 0.003264840214058112
Current ratio: 1.8551959996546847
Quick ratio: 1.3591133364765884
Retained earnings: -132128.7040220007
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for YHC — annual report dated 2022-12-31
Total revenue: 601131
Gross profit: -202013
Operating income: -1842175
Net income: -1842175
Capital expenditures: 0
Operating cash flow: -918197
Depreciation & amortization: 250000
Net tangible assets: -43692
Owner earnings: -1592175
Buffett classification: The Gruesome
Shares outstanding: 1303838
Book value: 2039641
Debt to equity: 0
Current ratio: 0.9260353977806557
Quick ratio: 0.9260353977806557
COGS to revenue (%): 133.6054869903565
SG&A to revenue (%): 272.8460185882944
Free cash flow (dilution-adjusted): -1236072
Retained earnings: -3804901
Receivables turnover: 2.675355597885105
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -90.31859037938538
FCF margin (%): -205.62439800975164
Rule of 40 score: -205.62439800975164
Financial ratios for 0496.HK — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 566670571.4285715
Buffett classification: The Gruesome
Stock price: 0.05398457583547558
Trailing EPS: 0.02
P/E ratio: 2.6992287917737787
Shares outstanding: 1836541352
Book value: 604888142.8571428
P/B ratio: 0.16390618176730573
Market cap (USD): 48537165.71428572
Yahoo trailing P/E: 9.25
EV/EBITDA: 8.44
Debt to equity: 0.243
Current ratio: 2.86
Quick ratio: 0.22
Buyback yield (%): 0
Retained earnings: 299289857.14285713
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0496.HK — annual report dated 2025-12-31
Total revenue: 158667857.14285713
Gross profit: 58751857.14285714
Operating income: 17212857.14285714
Net income: 10219142.857142856
Capital expenditures: 44898428.571428575
Operating cash flow: 8337714.285714285
Depreciation & amortization: 10710714.285714285
Net tangible assets: 566670571.4285715
Owner earnings: -23968571.428571433
Return on net tangible assets (%): -4.229718753198508
Capex to operating income (%): 260.84239355963155
Buffett classification: The Gruesome
Stock price: 0.05398457583547558
Trailing EPS: 0.02
P/E ratio: 2.6992287917737787
Shares outstanding: 1836541352
Book value: 604888142.8571428
P/B ratio: 0.16390618176730573
Market cap (USD): 48537165.71428572
Yahoo trailing P/E: 9.25
EV/EBITDA: 8.44
Debt to equity: 0.243
Current ratio: 2.86
Quick ratio: 0.22
Effective tax rate (%): 24.619324109297448
Interest coverage ratio: 3.258423927740819
COGS to revenue (%): 62.97179643009881
SG&A to revenue (%): 26.20676615571612
Free cash flow (dilution-adjusted): -44589285.71428572
Buyback yield (%): 0
Retained earnings: 299289857.14285713
Inventory turnover: 0.25602765666233374
Receivables turnover: 11.848463836142521
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.391951734547156
FCF margin (%): -28.102280144956897
Revenue growth (%): 12.92634498526916
Rule of 40 score: -15.175935159687736